Role of Receptor Binding and Gene Transcription for Both of Stimulatory and Inhibitory Effects of Interleukin-1 In Pancreatic β-Cells

References

• Nerup J., Mandrup-Poulsen T., Molvig J., Helqvist S., Wogensen L., Egeberg J. Mechanisms of pancreatic -cell destruction in type 1 diabetes. Diabetes Care 1988; 11(Suppl 1)16–23
   PubMedGoogle Scholar
• Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 1989; 2: 177–189
   PubMed Web of Science ®Google Scholar
• Spinas G. A., Palmer J. P., Mandrup-Poulsen T., Andersen H., Nielsen J. H., Nerup J. The bimodal effect of interleukin 1 on rat pancreatic beta cells-stimulation followed by inhibition-depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocrinol (Copenh) 1988; 119: 307–311
   PubMedGoogle Scholar
• Eizirik D. L., Sandler S. Human interleukin-1 induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events. Diabetologia 1989; 32: 769–773
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Mandrup-Poulsen T., Nerup J., Dinarello C. A., Svenson M., Nielsen J. H. Cytotoxicity of human pi 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Sandler S., Andersson A., HellerstrSm C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Borg L. AH., Eizirik D. L. Short-term exposure of rat pancreatic islets to human interleukin-1/} increases cellular uptake of calcium. Immunol Lett 1990; 26: 253–258
   PubMed Web of Science ®Google Scholar
• Mandrup-Poylsen T., Egeberg J., Nerup J., Bendtzen K., Nielsen J. H., Dinarello C. A. Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand [Sect C] 1987; 95: 55–63
   Google Scholar
• Sandler S., Bendtzen K., Borg L. A. H., Eizirik D. L., Strandell E., Welsh N. Studies on the mechanism causing inhibition of insulin secretion in rat pancreatic islets exposed to interleukin- 1 indicate a perturbation in the mitochondrial function. Endocrinology 1989; 124: 1492–1501
   PubMed Web of Science ®Google Scholar
• Hughes J. H., Colca J. R., Easom R. A., Turk J., McDaniel M. L. Interleukin 1 inhibits insulin secretion by a process that requires gene transcription and mRNA translation. J Clin Invest 1990; 86: 856–863
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Bendtzen K., Sandler S. Short exposure of rat pancreatic islets to interleukin-1 induces a sustained but reversible impairment in -cell function: in Fluence of protease activation, gene transcription, and protein translation. Endocrinology 1991; 128: 1611–1616
   PubMed Web of Science ®Google Scholar
• Eizirik D. L. Interleukin-1 induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 1991; 10: 107–113
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Tracey D. E., Bendtzen K., Sandler S. An interleukin-1 receptor antagonist protein (IRAP) protects insulin-producing beta-cells against suppressive effects of interleukin-1. Diabetologia 1991; 34: 445–448
   PubMed Web of Science ®Google Scholar
• Welsh N., Bendtzen K., Sandler S. In Fluence of protease on inhibitory and stimulatory effects of interleukin 1 on -cell function. Diabetes 1991; 40: 290–294
   PubMed Web of Science ®Google Scholar
• Carter D. B., Deibel M. R., Dunn C. J., Tomic C. S. C., Laborde A. L., Slightom J., Berger A. E., Bienkowski M. J., Sun F. F., McEwan R. N., Harris P. K. W., Yem A. W., Waszak G. A., Chosay J. G., Sieu L. C., Hardee M. M., Zurcher-Neely H. A., Reardon I. M., Heirinkson R. L., Truesdell S. E., Shelly J. A., Eessalu T. E., Taylor B. M., Tracey D. E. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344: 633–638
   PubMed Web of Science ®Google Scholar
• Svenson M., Bendtzen K. Interleukin 1 inhibitor in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line. Scand J Immunol 1988; 27: 593–599
   PubMed Web of Science ®Google Scholar
• Fanslow W. C., Sims J. E., Sassenfeld H., Morrissey P. J., Gillis S., Dower S. K., Widmer M. B. Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science 1990; 248: 739–742
   PubMed Web of Science ®Google Scholar
• Andersson A. Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia 1978; 14: 397–404
   PubMed Web of Science ®Google Scholar
• Krebs H. A., Henseleit K. Untersuchungen uber die Harnstoffbildung im Tierkörper. Hoppe-Sevlers Z Physiol Chem 1932; 210: 33–36
   Google Scholar
• Hinegardner R. T. An improved Fluorimetric assay for DNA. Anal Biochem 1971; 39: 197–201
   PubMed Web of Science ®Google Scholar
• Heding L. G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260–266
   PubMed Web of Science ®Google Scholar
• Andersson A., Sandler S. Viability tests of cryopreserved endocrine pancreatic cells. Cryobiology 1988; 20: 161–168
   Google Scholar
• Mandrup-Poulsen T., Bentzen K., Dinarello C. A., Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic yS-cell cytotoxicity. J Immunol 1987; 139: 4077–4082
   PubMed Web of Science ®Google Scholar
• Halban P. A., Wollheim C. B., Blondel B., Renold A. E. Long-term exposure of isolated pancreatic islets to manoheptulose: evidence for insulin degradation in the -cell. Biochem Pharmacol 1980; 29: 2625–2633
   PubMed Web of Science ®Google Scholar
• Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 8: 1627–1652
   Google Scholar
• Rosoff P. M., Savage N., Dinarello C. A. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 1988; 54: 73–81
   PubMed Web of Science ®Google Scholar
• Hammonds P., Beggs M., Beresford G., Espinal J., Clarke J., Mertz R. J. Insulin-secreting /J-cells possess specific receptors for interleukin-1/8. FEBS Lett 1990; 261: 97–100
   PubMed Web of Science ®Google Scholar
• Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336–340
   PubMed Web of Science ®Google Scholar
• Eisenberg S. P., Evans R. J., Arend W. P., Verderber E., Brewer M. T., Hannum C. H., Thompson R. C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 341–346
   PubMed Web of Science ®Google Scholar
• Arend W. P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family./. Clin Invest 1991; 88: 1445–1451
   Google Scholar
• Zahedi K., Seldin M. F., Rits M., Ezekowitz R. A. B., Whitehead A. S. Mouse IL-1 receptor antagonist protein. Molecular characterization, gene mapping, and expression of mRNA in vitro and in vivo. J Immunol 1991; 146: 4228–4233
   Google Scholar
• Eisenberg S. P., Brewer M. T., Verderber E., Heimdal P., Brand-huber B. J., Thompson R. C. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 1991; 88: 5232–5236
   PubMed Web of Science ®Google Scholar
• Dripps D. J., Branduber B. J., Thompson R. C., Eisenberg S. P. Interleukin-1 (IL-I) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J BiolChem 1991; 266: 10331–10336
   PubMed Web of Science ®Google Scholar
• Tracey D. E., Hardee M. M., Shelly J. A., Chosay J. G., Fidler S. F., Laborde A. L., Dunn C. IRAP blocks murine type 2 IL-1 receptors and inhibits IL-1 induced neutrophilia at high concentrations. Cell Biochem 1991, Suppl 15E: 177A
   Google Scholar
• Granowitz E. V., Clark B. D., Mancilla J., Dinarello C. A. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 1991; 266: 14147–14150
   PubMed Web of Science ®Google Scholar
• Chedid M., Shirakawa F., Naylor P., Mizel S. B. Signal transduction for IL-1. Involvement of a pertussis toxin-sensitive GTP-binding protein in the activation of adenylate cyclase. J of Immunol 1989; 142: 4301–4306
   PubMed Web of Science ®Google Scholar
• Dobson P. R. M., Plested C. P., Jones D. R., Barks T., Brown B. L. Interleukin-1 induces a pertussis-toxin sensitive increase in diacylglycerol accumulation in mouse thymoma cells. J ofMol Endocr 1989; 2: R5–R8
   Google Scholar
• O'Neill L. A. J., Bird T. A., Saklatvala J. Interleukin-1 signal transduction. Immunology Today 1990; 11: 392–394
   PubMedGoogle Scholar
• Neer E. J., Clapham D. E. Roles of G protein subunits in transmembrane signalling. Nature 1988; 333: 129–134
   PubMed Web of Science ®Google Scholar
• Mizel S. B. Cyclic AMP and interleukin 1 signal transduction. Immunology Today 1990; 11: 390–391
   PubMedGoogle Scholar
• Hughes J. H., Watson M. A., Easom R. A., Turk J., McDaniel M. L. Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified -cells. FEBS Lett 1990; 266: 33–36
   PubMed Web of Science ®Google Scholar
• Borg L. A. H., Sandler S., Eizirik D. L. Interleukin-1 increases the activity of superoxide dismutase in rat pancreatic islets. Dia-betologia 1991; 34(Suppl 2)A8
   Google Scholar
• Eizirik D. L. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol (Copenh) 1988; 119: 321–325
   PubMedGoogle Scholar
• Eizirik D. L., Sandler S., Hallberg A., Bendtzen K., Sener A., Malaisse W. J. Differential sensitivity to -cell secretagogues in rat pancreatic islets exposed to human interleukin-1. Endocrinology 1989; 125: 752–759
   PubMed Web of Science ®Google Scholar
• Sandler S., Bendtzen K., Eizirik D. L., Strandell E., Welsh M., Welsh N. Metabolism and -cell function of rat pancreatic islets exposed to human interleukin-1/? in the presence of a high glucose concentration. Immunol Lett 1990; 26: 245–252
   PubMed Web of Science ®Google Scholar